| The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation LH Parker, M Schmidt, SW Jin, AM Gray, D Beis, T Pham, G Frantz, ... Nature 428 (6984), 754-758, 2004 | 495 | 2004 |
| Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice J Lau, J Cheung, A Navarro, S Lianoglou, B Haley, K Totpal, L Sanders, ... Nature communications 8 (1), 14572, 2017 | 375 | 2017 |
| EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution M Schmidt, K Paes, A De Mazière, T Smyczek, S Yang, A Gray, D French, ... Oxford University Press for The Company of Biologists Limited 134 (16), 2913 …, 2007 | 262 | 2007 |
| Neuropilin‐1 expression in cancer and development AM Jubb, LA Strickland, SD Liu, J Mak, M Schmidt, H Koeppen The Journal of pathology 226 (1), 50-60, 2012 | 247 | 2012 |
| Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy A Bagri, L Berry, B Gunter, M Singh, I Kasman, LA Damico, H Xiang, ... Clinical Cancer Research 16 (15), 3887-3900, 2010 | 173 | 2010 |
| The chicken talpid3 gene encodesa novel protein essentialfor Hedgehog signaling MG Davey, IR Paton, Y Yin, M Schmidt, FK Bangs, DR Morrice, TG Smith, ... Genes & development 20 (10), 1365-1377, 2006 | 139 | 2006 |
| Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer AM Jubb, KD Miller, HS Rugo, AL Harris, D Chen, JD Reimann, ... Clinical Cancer Research 17 (2), 372-381, 2011 | 123 | 2011 |
| Childhood muscular fitness phenotypes and adult metabolic syndrome. B Fraser, Q Huynh, M Schmidt, T Dwyer, A Venn, C Magnussen Medicine and science in sports and exercise 48 (9), 2016 | 103 | 2016 |
| Expression of β-catenin in the developing chick myotome is regulated by myogenic signals M Schmidt, M Tanaka, A Münsterberg Development 127 (19), 4105-4113, 2000 | 96 | 2000 |
| Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents CC Ong, S Gierke, C Pitt, M Sagolla, CK Cheng, W Zhou, AM Jubb, ... Breast Cancer Research 17, 1-12, 2015 | 72 | 2015 |
| Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies MJ Brauer, G Zhuang, M Schmidt, J Yao, X Wu, JS Kaminker, SS Jurinka, ... Clinical Cancer Research 19 (13), 3681-3692, 2013 | 65 | 2013 |
| Neuropilin‐2 expression in cancer AM Jubb, SM Sa, N Ratti, LA Strickland, M Schmidt, CA Callahan, ... Histopathology 61 (3), 340-349, 2012 | 47 | 2012 |
| Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy L Johnson, M Huseni, T Smyczek, A Lima, S Yeung, JH Cheng, R Molina, ... The Journal of clinical investigation 123 (9), 3997-4009, 2013 | 45 | 2013 |
| Dynamic expression of Lef/Tcf family members and β‐catenin during chick gastrulation, neurulation, and early limb development M Schmidt, M Patterson, E Farrell, A Münsterberg Developmental dynamics: an official publication of the American Association …, 2004 | 45 | 2004 |
| The Role of Egfl7 in Vascular Morphogenesis M Schmidt, A De Mazière, T Smyczek, A Gray, L Parker, E Filvaroff, ... Vascular Development: Novartis Foundation Symposium 283 283, 18-36, 2007 | 44 | 2007 |
| Genomic organization and fine mapping of the keratin 2e gene (KRT2E): K2e V1 domain polymorphism and novel mutations in ichthyosis bullosa of Siemens FJD Smith, C Maingi, SP Covello, C Higgins, M Schmidt, EB Lane, J Uitto, ... Journal of investigative dermatology 111 (5), 817-821, 1998 | 37 | 1998 |
| The In Vivo Activity of Vascular Endothelial Growth Factor Isoforms in the Avian Embryo M Schmidt, I Flamme Growth Factors 15 (3), 183-197, 1998 | 28 | 1998 |
| Phase 1a/1b study of first-in-class B7-H4 antibody, FPA150, as monotherapy in patients with advanced solid tumors. JC Sachdev, TM Bauer, SP Chawla, S Pant, A Patnaik, ZA Wainberg, ... Journal of Clinical Oncology 37 (15_suppl), 2529-2529, 2019 | 18 | 2019 |
| MHC class I presented antigens from malignancies: A perspective on analytical characterization & immunogenicity M Schmidt, JR Lill Journal of proteomics 191, 48-57, 2019 | 18 | 2019 |
| 23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function J Fenaux, X Fang, Y Huang, C Melero, C Bonnans, EL Lowe, T Palumbo, ... Oncoimmunology 12 (1), 2217737, 2023 | 11 | 2023 |
